Surprise CE Mark for Stentys Xposition S stent
Stentys this week said it won a CE Mark ahead of schedule for its latest self-apposing coronary stent, a product that will be used with delivery system technology it acquired last June.
Study finds biomarkers linked to NFL players’ brain injuries
Boston Scientific inks DBS deal with Brainlab
Haemonetics ends its fiscal year in Q4 red
Haemonetics (NYSE:HAE) finished out its 2015 fiscal 4th quarter in the red, hammered by a U.S. market shift that affected its blood center business, uncertainty in Russia, currency fluctuations and restructuring.
Contego Medical raises $6m for embolic filter tech
Tendyne mitral valve study launches in U.S.
Tendyne Holdings this month said its transcatheter mitral valve implant was implanted in the 1st U.S. patient as part of a global feasibility study.
Gynesonics raises $3m for VizAblate fibroid device
California’s Gynesonics reported raising $3 million in a new debt offering as it pursues development of its VizAblate fibroid treatment device.
Reva Medical extends Fantom stent trial to Europe
Spirox lands $19m Series B round
Spirox said this week that it nailed down an $18.5 million Series B round to back development and commercialization of its device to treat patients with nasal obstructions.
Venrock and Aisling Capital led the round for Menlo Park, Calif.-based Spirox, with existing investors Aperture Venture Partners, Correlation Ventures and Western Technology Investment also participating.